1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College January.

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
Plumbing 101 or How a good boy went bad Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Improving Candidate Quality Through the Prediction of Clinical Outcome.
Human Body Drug Simulation Nathan Liles Benjamin Munda.
Mathematic descript. of A) Biolog. processes affecting drugs B) Biolog. processes affected by drugs drugs Pharmacokinetics Mathematical expressions to.
1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College March.
Computational Biology, Part 18 Compartmental Analysis Robert F. Murphy Copyright  1996, All rights reserved.
One-compartment open model: Intravenous bolus administration
Lead in the Body Using Euler’s Method to Explore Compartment Models Maria Hernandez NCSSM TCM January 2007
Pharmacokinetics Chapter 4.
Blood Glucose Regulation BIOE Glucose Regulation Revisited input: desired blood glucose output: actual blood glucose error: desired minus measured.
Laplace transformation
Week 4 - Biopharmaceutics and Pharmacokinetics
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Gokaraju Rangaraju College of Pharmacy
Species extrapolation with PBPK models
ADME And PHARMACOKINETICS.
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Biotransformation and metabolism
Analytical Toxicology Pharmacokinetics and Pharmacodynamics.
You have learned a LOT so far. A few extra facts to throw in No single reproducible abnormality in any NT, enzyme, receptor or gene has been found to.
PHARMACOKINETICS.
A Physiological Based Description of the Inhalation Pharmacokinetics of Styrene in Rats and Humans John C. Ramsey and Melvin E. Andersen Toxicology and.
From A Physiologic Perspective Chemical Clearance from the Body
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
Louisiana Tech University Ruston, LA Slide 1 Compartmental Models Juan M. Lopez BIEN 501 Friday, May 09, 2008.
Bioavailability Dr Mohammad Issa.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
PHARMACOKINETICS Part 3.
Biopharmaceutics refers to the relationship of the:
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
The General Concepts of Pharmacokinetics and Pharmacodynamics
!!!……Molecular Target Concept A gonist Antagonist.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
TDM Therapeutic Drug Monitoring
© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.
PHT 415 BASIC PHARMACOKINETICS
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
Compartmental Modelling
Pharmacokienetic Principles (2): Distribution of Drugs
Physiology for Engineers
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Pharmaceutics 2.
Gretchen A. Koch Goucher College BioQUEST Summer 2007
Kinetics, Modeling Oct 19, 2009 Casarett and Doull,
Now let’s consider delivery from a solid drug in a polymeric matrix.
Dosimetry and Kinetics
Pharmacokinetics & pharmacodynamcs
Kinetics, Modeling Oct 15, 2006 Casarett and Doull,
Clinical Pharmacokinetics
Hawler Medical University
Basic Biopharmaceutics
Hawler Medical University
Clinical Pharmacokinetics
Introduction to Pharmacology
Project #1: Drug Kinetics in Genetically Modified Mice
Presentation transcript:

1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College January 7, 2007

2 Outline Introduction to compartment models Research examples Linear model –Analytics –Graphics Nonlinear model Exploration

3 Physiologically Based Pharmacokinetic (PBPK) Models in Toxicology Research A physiologically based pharmacokinetic (PBPK) model for the uptake and elimination of a chemical in rodents is developed to relate the amount of IV and orally administered chemical to the tissue doses of the chemical and its metabolite.

4 Characteristics of PBPK Models Compartments are to represent the amount or concentration of the chemical in a particular tissue. Model incorporates known tissue volumes and blood flow rates; this allows us to use the same model across multiple species. Similar tissues are grouped together. Compartments are assumed to be well-mixed.

5 Example of Compartment in PBPK Model Q K is the blood flow into the kidney. CV K is the concentration of chemical in the venous blood leaving the kidney. QKQK CV K Kidney

6 Example of Compartment in PBPK Model C K is the concentration of chemical in the kidney at time t. C Bl is the concentration of chemical in the blood at time t. CV K is the concentration of chemical in the venous blood leaving the kidney at time t. Q K is the blood flow into the kidney. V K is the volume of the kidney.

7 Benzene Aveloar Space Lung Blood Fat Slowly Perfused Rapidly Perfused Liver Stomach Muconic Acid ExhaledInhaled Venous Blood CV Arterial Blood CA Slowly Perfused Blood Liver Blood Liver Blood Liver BO PH HQ BZ Conjugates PH Catechol THB Conjugates HQ PMA Benzene Benzene OxidePhenolHydroquinone Rapidly Perfused Fat BOPH Slowly Perfused PH Fat PH Rapidly Perfused Fat Slowly Perfused Rapidly Perfused HQ

8 Benzene Plot

9

10 4-Methylimidazole (4-MI) Other Tissues Adipose Kidney Urine Liver BloodBlood Initial condition: IV exposure Stomach Initial condition: gavage exposure Feces Metabolite

11 4-MI Female Rat Data (NTP TK)

12 4-MI Female Rat Data (Chronic)

13 Linear Model Example A drug or chemical enters the body via the stomach. Where does it go? Assume we can think about the body as three compartments: –Stomach (where drug enters) –Liver (where drug is metabolized) –All other tissues Assume that once the drug leaves the stomach, it can not return to the stomach.

14 Schematic of Linear Model x 1, x 2, and x 3 represent amounts of the drug in the compartments. a, b, and c represent linear flow rate constants. Stomach Other Tissues Liver x2x2 x1x1 x3x3 a bc

15 Linear Model Equations Let’s look at the change of amounts in each compartment, assuming the mass balance principle is applied.

16 Linear Model Equations Let’s look at the change of amounts in each compartment, assuming the mass balance principle is applied.

17 Linear Model (continued) Let’s now write the system in matrix form.

18 Linear Model (continued) Find the eigenvectors and eigenvalues. Write general solution of the differential equation. Use initial conditions of the system to determine particular solution.

19 Finding Eigenvalues

20 Finding Eigenvectors Consider

21 Finding Eigenvectors

22 Finding Eigenvectors Consider

23 Finding Eigenvectors

24 Finding Eigenvectors Consider

25 Finding Eigenvectors

26 Linear Model (continued) Then, our general solution would be given by:

27 Parameter Values and Initial Conditions For our example, let a=3, b=4, and c=1, and use the initial conditions of we are representing the fact that the drug began in the stomach and there were no background levels of the drug in the system.

28 Linear Model (continued) Then, our particular solution would be given by: with

29 Graphical Results Link1 Link2 Link1 Link2

30 Schematic of Nonlinear Model x 1, x 2, x 3, and x 4 represent amounts of the drug (or its metabolite). Liver x2x2 Stomach x1x1 a Other Tissues x3x3 bc Metabolite x4x4

31 Nonlinear Model Equations

32 Nonlinear Model Link 1 Link2 a=0.2, b=0.4, c=0.1, V=0.3, K=4 Link 1Link2

33 Exploration What would happen if the parameter values were changed? What would happen if the initial conditions were changed? We will now use Phaser to explore these questions.